Elizabeth F. Redente, PhD Ask a Question Refer Patient Elizabeth F. Redente, PhD, is a researcher and Science Leader for the Office of Research Innovation at National Jewish Health. Dr. Redente is in the Division of Cell Biology and Department of Pediatrics. Associate Professor Science Leader for the Office of Research Innovation Department of Pediatrics Division of Cell Biology Castle Connolly & 5280 Top Doctors 2023 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Overview Contact Info & Locations Programs & Services Cell Biology Specialties & Conditions Interstitial Lung Disease (ILD)/Pulmonary Fibrosis Research Areas Fibroblast biology Interstitial Lung Disease (ILD) Macrophage Biology Pulmonary Fibrosis Special Interests My career interests are focused on the interactions between TNF-α, macrophages and myofibroblasts and their role in the resolution of established pulmonary fibrosis with the goal to investigate the mechanisms by which TNF-α resolves fibrosis as the basis for the translational application of this work as a potential therapeutic. We plan to elucidate the mechanisms by which TNF-α is reducing the pro-fibrotic phenotype of macrophages and myofibroblasts and via the creation of an anti-fibrotic lung microenvironment. The importance of understanding how macrophages are shaping the lung environment during disease and how these interactions can be modulated to influence disease resolution is an important research direction that can be applied to many diseases including fibrosis and cancer. It is my goal that my basic science findings conducted in mouse models be translatable to human disease and into potential therapeutic treatments. See More View Publications News & Videos Elizabeth Redente Honored for Scientific Achievement Education Education University of Colorado Denver, PhD Publications Redente EF. How Do We Know What We Are Missing? Loss of Signaling through CD148 Drives Fibroblast Activation in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021 Aug 1;204(3):249-251. doi: 10.1164/rccm.202103-0737ED. PubMed PMID: 33891825; PubMed Central PMCID: PMC8513589. Guzy R, Redente EF. Kindlin for the Fire: Targeting Proline Synthesis to Extinguish Matrix Production in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021 Jul;65(1):4-5. doi: 10.1165/rcmb.2021-0137ED. PubMed PMID: 33844940; PubMed Central PMCID: PMC8320124. Academic Affiliations Associate Professor of the University of Colorado School of Medicine, Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine Ask a Question through MyChart Sign in to your MyChart account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 303.398.1548 Email: RedenteE@njhealth.org Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.